Arrhythmogenic Right Ventricular Cardiomyopathy: Difference between revisions

Arrhythmogenic Right Ventricular Cardiomyopathy (view source)

Revision as of 16:12, 1 August 2007

1 byte added , 1 August 2007

m

no edit summary

Drj

Bureaucrats, Administrators

4,200

edits

@@ Line 17: / Line 17: @@
 One unique form of ARVD, called Naxos disease (after the Greek island where it was first diagnosed), has an autosomal recessive pattern of inheritance.
-'''Diagnosis''' ARVC is a difficult diagnosis to make. Therefore, the European Society of Cardiology has created a list of diagnositc criteria for the diagnosis of ARVC<cite>#McKenna1994</cite>
+'''Diagnosis''' ARVC is a difficult diagnosis to make. Therefore, the European Society of Cardiology has created a list of diagnositc criteria for the diagnosis of ARVC<cite>#McKenna1994</cite> (see table).
-===Treatment===
-Treatment focusses on avoiding complications.<cite>ACC2006</cite>
-*Medication:
-**anti-arrithmics: Amiodarone, Sotalol
-**ACE-inhibitors to prevent cardiac remodelling
-*[[ICD]] implantation is recommended for the prevention of sudden cardiac death in patients with ARVC with documented sustained VT or VF who are receiving chronic optimal medical therapy.
-*[[ICD]]] implantation can be considered for the prevention of sudden cardiac death in patients with ARVC with extensive disease, including those with left ventricular involvement, 1 or more affected family member with SCD, or undiagnosed syncope when [[Ventricular Tachycardia|ventricular tachycardia]] or [[Ventricular Fibrillation|ventricular Fibrillation]] has not been excluded as the cause of syncope, who are receiving chronic optimal medical therapy, and who have reasonable expectation of survival with a good functional status for more than 1 y.
-*Radiofrequency [[ablation]] can be useful as adjunctive therapy in management of patients with ARVC with recurrent [[Ventricular Tachycardia|ventricular tachycardia]], despite optimal antiarrhythmic drug therapy.
 {| class="wikitable" align="left" width="400px"
 !Major diagnostic criteria for Aritmogenic Right Ventricular Cardiomyopathy<cite>McKenna1994</cite>
@@ Line 49: / Line 39: @@
 |}
 [[Image:epsilon_wave.png|thumb|ECG with an epsilon wave in V1]]
+'''Treatment''' focuses on avoiding complications.<cite>ACC2006</cite>
+*Medication:
+**anti-arrithmics: Amiodarone, Sotalol
+**ACE-inhibitors to prevent cardiac remodelling
+*[[ICD]] implantation is recommended for the prevention of sudden cardiac death in patients with ARVC with documented sustained VT or VF who are receiving chronic optimal medical therapy.
+*[[ICD]]] implantation can be considered for the prevention of sudden cardiac death in patients with ARVC with extensive disease, including those with left ventricular involvement, 1 or more affected family member with SCD, or undiagnosed syncope when [[Ventricular Tachycardia|ventricular tachycardia]] or [[Ventricular Fibrillation|ventricular Fibrillation]] has not been excluded as the cause of syncope, who are receiving chronic optimal medical therapy, and who have reasonable expectation of survival with a good functional status for more than 1 y.
+*Radiofrequency [[ablation]] can be useful as adjunctive therapy in management of patients with ARVC with recurrent [[Ventricular Tachycardia|ventricular tachycardia]], despite optimal antiarrhythmic drug therapy.
 ==Referenties==
 <biblio>